Tenax Therapeutics (TENX) Assets Average (2011 - 2026)

Tenax Therapeutics has disclosed Assets Average across 14 years of filings, most recently posting $122.4 million for Q2 2026.

• In Q2 2026, Assets Average rose 12.36% year-over-year to $122.4 million; the TTM figure through Jun 2026 stood at $122.4 million (up 12.36% YoY), while the FY2025 annual figure was $100.5 million, up 85.39% from the prior year.
• Assets Average came in at $122.4 million for Q2 2026 at Tenax Therapeutics, up from $113.7 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $122.4 million in Q2 2026 to a low of $4.1 million in Q4 2022.
• Average Assets Average over 5 years is $50.4 million, with a median of $13.9 million recorded in 2023.
• Year-over-year, Assets Average plunged 45.36% in 2022 and surged 768.98% in 2025.
• Over 5 years, Assets Average stood at $4.1 million in 2022, then jumped by 189.47% to $11.8 million in 2023, then surged by 733.42% to $98.2 million in 2024, then increased by 5.38% to $103.5 million in 2025, then increased by 18.26% to $122.4 million in 2026.
• Per Business Quant data, the three most recent Assets Average figures were $122.4 million in Q2 2026, $113.7 million in Q1 2026, and $103.5 million in Q4 2025.